CIK 0000883984 · Large accelerated filer
ICU MEDICAL INC/DE
Sign in to watch- Ticker
- ICUI
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330022692
- Phone
- 949-366-2183
- Business address
- 951 CALLE AMANECER, SAN CLEMENTE, CA, 92763-6212
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,543,969
- in 3 filings, $3.5M under 10b5-1 plans
Net −$3,543,969. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-03 | Jain Vivek Chairman and CEO | Option exercise 10b5-1 | +3,755 | $88.76 | $333K | 108,348 |
| 2024-09-03 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −3,755 | $162.69 | $611K | 104,593 |
| 2024-09-03 | Jain Vivek Chairman and CEO | Option exercise 10b5-1 | +4,440 | $88.76 | $394K | 109,033 |
| 2024-09-03 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −4,440 | $163.59 | $726K | 104,593 |
| 2024-09-03 | Jain Vivek Chairman and CEO | Option exercise 10b5-1 | +3,805 | $88.76 | $338K | 108,398 |
| 2024-09-03 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −3,805 | $164.07 | $624K | 104,593 |
| 2024-09-03 | Jain Vivek Chairman and CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −3,755 | $88.76 | $333K | 45,618 |
| 2024-09-03 | Jain Vivek Chairman and CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −4,440 | $88.76 | $394K | 41,178 |
| 2024-09-03 | Jain Vivek Chairman and CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −3,805 | $88.76 | $338K | 37,373 |
| 2024-08-30 | Woolson Daniel VP, GM-Infusion Capital | Sale | −2,502 | $163.22 | $408K | 13,107 |
| 2024-08-16 | Jain Vivek Chairman and CEO | Option exercise 10b5-1 | +12,000 | $88.76 | $1.1M | 116,593 |
| 2024-08-16 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −12,000 | $156.04 | $1.9M | 104,593 |
| 2024-08-16 | Jain Vivek Chairman and CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −12,000 | 49,373 | ||
| 2024-08-08 | Sanzone Virginia Ruth VP, General Counsel | Sale 10b5-1 | −2,050 | $144.11 | $295K | 4,482 |
| 2024-05-30 | Voigtlander Christian B. Chief Operating Officer | Sale | −10,507 | $103.85 | $1.1M | 2,032 |
| 2024-05-30 | Voigtlander Christian B. Chief Operating Officer | Sale | −2,032 | $104.49 | $212K | 0 |
| 2024-05-16 | FINNEY ELISHA W Director | Sale | −300 | $104.95 | $31K | 2,129 |
| 2024-05-15 | Hernandez Laurie Director | Option exercise | +948 | 1,885 | ||
| 2024-05-15 | Hernandez Laurie Director | Option exercise · Common Stock | −948 | 0 | ||
| 2024-05-15 | Hernandez Laurie Director | Grant or award · Common Stock | +1,723 | 1,723 |
Page 14 of 44 · 868 trades